Тёмный
No video :(

Orphan Drug Development | Episode 04 - How to get Orphan Drug Designation in European Union | DRA 

PharmaCamp
Подписаться 3 тыс.
Просмотров 588
50% 1

Welcome to the PharmaCamp with Neha. This is a small initiative from my side to share knowledge about the pharmaceutical world and regulatory, as I feel education is the best gift one can receive or give back to society.
Are you a working professional who wants to upgrade your skills? OR a student who wants to make a career in pharmaceuticals? OR are you a person who is interested to learn about the regulatory systems? Then this RU-vid channel is for you.
About me:
I am Neha Parashar, working as a Associate Director in a pharmaceutical company and based in Germany. I am a passionate healthcare professional, an educator, and a mentor.
In this series 'Orphan Drug Development', I will discuss the regulatory aspects related to orphan drugs.
Channel Introduction- Welcome to PharmaCamp • Welcome to PharmaCamp ...
Series 1 -Regulatory Learnings | Investigational New Drug (IND) Application
• Regulatory Learnings |...
Series 2-Regulatory Shorts
• Regulatory Shorts
Series 3-EU Marketing Authorisation
• EU Marketing Authorisa...
Series 4-Dare to Lead with Neha | An Interview Series with Pharma Leaders
• Dare To Lead - An Inte...
Series 5-Orphan Drug Development
• Orphan Drug Development
LinkedIn: / neha-parashar
LinkedIn Articles on various Regulatory Topics:
1. Regulatory Pathways for Expedited Access of Medicines / regula. .
2. Step-wise Regulatory approach for the Paediatric drug Development / step-w. .
3. Designing the Global Regulatory Strategy for the Development of Orphan Medicinal Products
/ design. .
4. Step wise approach for Quality Risk Management (QRM) in pharmaceutical industries / step-w. .
5. Step-wise regulatory approach for the assessment of process related impurities in biological products / step-w. .
6. Step-wise approach for sterilisation package preparation in regulatory dossiers for biologicals and other liquid sterilised products / step-w. .
7. Step-wise approach for regulatory risk assessment of adventitious agents in biologicals products / step-w. .
8. Five Step Approach to Assess Equivalency Requirements of Topical Products / five-s. .
Disclaimer- This video channel is for educational purposes. These are purely my views and not any recommendations. The channel does not represent the views of the organization I am associated with, and it has no connection with my current organization.

Опубликовано:

 

17 дек 2022

Поделиться:

Ссылка:

Скачать:

Готовим ссылку...

Добавить в:

Мой плейлист
Посмотреть позже
Комментарии : 8   
@nileshbawane842
@nileshbawane842 Год назад
Nice one .. Crystal clear.. Waiting for next video
@pharmacamp
@pharmacamp Год назад
Thanks Nilesh 😊
@arpitjaiswal272
@arpitjaiswal272 Год назад
As always,very informative
@pharmacamp
@pharmacamp Год назад
Thanks Arpit
@ThePhani9999
@ThePhani9999 Год назад
Thanks neha for sharing valuable information
@pharmacamp
@pharmacamp Год назад
Thanks Phani
@LearnPharma480
@LearnPharma480 Год назад
Good evening mam
@narasimhamurthykaki1938
@narasimhamurthykaki1938 Год назад
Medam, please suggest me any book on regulatory affairs to understand easily
Далее
What are Orphan Medicines? - Video explainer
3:18
Просмотров 2,7 тыс.